Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR
Luiza Handschuh(Institute of Bioorganic Chemistry, Polish Academy of Sciences), Marek Figlerowicz(Poznań University of Technology), Barbara Uszczyńska-Ratajczak(Institute of Bioorganic Chemistry, Polish Academy of Sciences), Marek Milewski(Institute of Bioorganic Chemistry, Polish Academy of Sciences), Mieczysław Komarnicki(Poznan University of Medical Sciences), Magdalena Łuczak(Institute of Bioorganic Chemistry, Polish Academy of Sciences), Michał Gï¿ ⁄ ralski(Institute of Bioorganic Chemistry, Polish Academy of Sciences), Marzena Wojtaszewska(Poznan University of Medical Sciences), Maciej Kaźmierczak(Silesian University of Technology), Krzysztof Lewandowski(Poznan University of Medical Sciences)
Cited by 80
Related Papers
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2022|453
Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia
|Blood Advances|2020|109
Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial
|Journal of Clinical Oncology|2022|93
RNA degradome--its biogenesis and functions
|Nucleic Acids Research|2011|55